VOLITIONRX LTD (VNRX)
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
Sector: In Vitro & In Vivo Diagnostic Substances
Industry: Medical - Devices
VolitionRX Ltd
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 30.06M shares outstanding
USVolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia.
The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.
It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
Leadership
Cameron Reynolds
Founder, Chief Executive Officer, President & Director
Dr. Alan Colman
Dr. Alan Colman(3)
Director
Dr. Ethel Rubin
Employees
57
Country
US
Sector
Healthcare
Website
volition.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Batchelor Ann-Louise | Group Chief Marketing Officer | Grant/Award | 12.0K | -- | Oct 21, 2026 |
 Forterre Gael | Chief Commercial Officer | Automatic Sell | 5.3K | $997.69 | Mar 17, 2026 |
 Rootsaert Rodney Gerard | Secretary | Automatic Sell | 3.9K | $750.12 | Mar 17, 2026 |
 Micallef Jacob Vincent | Chief Scientific Officer | Automatic Sell | 5.3K | $1.0K | Mar 17, 2026 |
 Plummer Nicholas | GC - Volition Diagnostics | Automatic Sell | 7.0K | $1.3K | Mar 17, 2026 |
| Rootsaert Rodney Gerard | Secretary | Automatic Sell | 3.3K | $707.373 | Mar 1, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Lagoda Investment Management, L.P. · also on 13F· joint filing· filed Sep 2026 | 1.5M+171.1K via warrants | 5.5% | 13D |
Lagoda Investment Management, L.P. | 1.5M | 4.8% | 13F |
Armistice Capital, LLC · may incl. warrants· filed Feb 2026 | 322.5K | 1.1% | 13G |
LUMINUS MANAGEMENT LLC | 156.9K | 0.5% | 13F |
Cameron Reynolds · may incl. warrants· stale · filed Feb 2024 | 143.4K | 0.5% | 13D |
 STILL TIMOTHY I Director | 81.3K | 0.3% | FORM 4 |
Miller Financial Services LLC | 71.0K | 0.2% | 13F |
 Innes Guy Archibald Director | 62.6K | 0.2% | FORM 4 |
GEODE CAPITAL MANAGEMENT, LLC | 55.5K | 0.2% | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 50.7K | 0.2% | 13F |
Insiders
- Batchelor Ann-LouiseGroup Chief Marketing Officer
- Forterre GaelChief Commercial Officer
- Rootsaert Rodney GerardSecretary
- Micallef Jacob VincentChief Scientific Officer
- Plummer NicholasGC - Volition Diagnostics
- Kway JasmineCEO - Singapore Volition
- Hughes TerigChief Financial Officer
- Reynolds Cameron JohnPresident and CEO
- Innes Guy ArchibaldDirector
- Nguyen KimDirector
based on 30.06M shares outstanding
US30d Avg
1.54M
60d Avg
2.43M
90d Avg
8.93M